Member Info for Uncanny

Valju, half here are just agreeing with you because it suits their deramping agenda.

Just the spread widened RC as have been offered at .45p all day.

Haha Don’t know but been doing dummy trades and all those 0.4 and over trades appear to all be buys.

One day Rodders!

Just done a dummy trade and 0.405 or higher is a buy online.

Well now appears to be more buyers than seller, albeit very quiet (£4000 worth of trades) which appears we are just sitting awaiting news and not the death spiral big sell off as the doomsayers keep staying.

Well 0.0003p, lol.

Well done on SOLG mate - just shows a bit of patience if you believe in the product will pay off in time. The lifeblood of a company is its cashflow and VAL now have that whether people like the Blue Ocean deal or not. They’re here to stay IMHO!

Well Flipsome, nobody with an alternative view when asked ever says what there position is so one can assume they don’t have one. For example, I’m a long fully paid up shareholder with a 1p average, with no margined products or spreadbets. What are you?

I agree OB Makes no difference here - just banter and oneupmanship. Stick to official RNS’s and other company newsflow.

Lol Obelix. Pleased for SCLP but don’t know why the need to slate VAL constantly on BB’s, it will hardly helps SCLP will it?

I back up with company facts, yours is all hearsay, conjecture and opinions.

In response: 1. Yes it says quite clearly in the RNS the money will be used to complete PC of 301 and CT of 201 - you even quoted that yourself. 2. You are confusing this with 201 - 201 had a 30% reduction in PSA and 301 a 50% reduction in legion growth. 3. Yes, why buy FIT to compliment 101 if its not working? The acquisition of FIT was an opportunity as the licensing to use FIT IP was too expensive for VAL. Listen to GM on the audiocasts: IP - https://www.brrmedia.co.uk/broadcasts/5ccad97b27121b6ec432ec90/valirx-acquisition-of-intellectual-property-jv-agreement 101 - https://www.brrmedia.co.uk/broadcasts/5ad872da391f790613b1beac/valirx-positive-results-from-val101 4. Agree, VAL had little financing options, but they have got their £1mn so yes the alternative was bleak without it, but they got it, plus 2 years extra money to get the main products to a point of commercialisation. 5. No, this 201 phase takes us to 16mg, with 4mg showing 30% reduction in PSA. Get to 50% and we are on par with Aberitarone which is the leading world prostate drug. 6. We agree. Why the funding? Well thats obvious isn’t it? GM in the BRR audiocast said we’ll get updates on the compounds and the JV’s - lets reserve judgement until then. 7. Listen to Satu’s presentation at the UK Investor forum - all very clear to hear in front of 24 delegates on the 309 days etc. You say “Also, they were not 'anonymous peers' that signed it off it was one Ex - employee !” Who was the ex-employee please? I’ll ask Suzy on that, TIA. Listen to Suzanne Dilly’s audiocast about the peer process: https://www.brrmedia.co.uk/broadcasts/5c18cf03e4f771677182a539/valirx-article-accepted-for-publication-of-val401 Think that answers all IMHO and we will just have to agree to disagree on certain points, but l have backed up what l can with company information. The rest of info you need is available on the VAL website under RNS’s

Quite true Valju, misleading T&S’s

I would refer everyone to Tricky’s post of a week ago that clearly showed a number of Blue Ocean turnaround stories, some multi bagged for some balance. The market is the best barometer IMHO by far and we are not capitulating, nobody is selling off and if anything the price looks posed for the next product news story to unfold. What do we want to hear? Compounds are running in line or exceeding targets - yes! I do believe this year will be pivotal as everything is now coming to fruition. Most bios have to lose a compound or two during trials but VAL has 4 globally patented, ALL successful with 101 in PC and LoI signed, 201 next phase finished this month and potential early deal, 301 starting CT and 401 with 2 x LoI’s signed already. 101 and 401 no more funding, 301 funded to enter CT and 201 final phase and if a deal then funding stops there and our cash burn falls by circa 70% to a year ago. It is easy to criticise what we can’t see or don’t know yet, but lets focus on FACTS on what WE CAN See.

All working overtime, so looks like the worm has turned chaps. Up 12.5% today and you don’t like it. Hey, what news is up next?????? Boom!!!

Here you go Roses: Dr Satu Vainikka, CEO of ValiRx, commented: "This investment into the Company at a premium to the recent share price is an exciting endorsement of our work to develop ground-breaking anti-cancer drugs and it will enable us to conclude the current trial of VAL201 and will provide us with a funding pathway to add real value to our VAL301 pre-clinical asset." Read and weep fella.

Yep Woody!

What Borgie, sell at 0.43 but buy at 0.6?????? Thats called a loss in my books! Ridiculous statement.

Can’t be EHGO as they don’t have their first tranche of sub shares yet as not showing on the LSE as issued the first 71mn shares.